Search results for "Antivirals"
Updated hearing loss guideline clarifies timing of interventions, changes terminology
For sudden hearing loss, urgent evaluation and initiation of treatment are important, according to a guideline update from the American Academy of Otolaryngology–Head and Neck Surgery.
https://immattersacp.org/weekly/archives/2019/08/13/4.htm
13 Aug 2019
HCV treatment by NPs, PCPs appears safe, effective as that provided by subspecialists
Reversing restrictions that limit prescribing of direct-acting antivirals might allow rapid escalation of safe, effective therapy for hepatitis C virus (HCV) infection and could improve the care of patients, study authors noted.
https://immattersacp.org/weekly/archives/2017/08/08/2.htm
8 Aug 2017
Be proactive about managing hepatitis B
Reports and other guidance on both hepatitis B virus prevention and treatment all have reprised a common theme: Clearly vulnerable individuals are too often missed.
https://immattersacp.org/archives/2018/04/be-proactive-about-managing-hepatitis-b.htm
1 Apr 2018
Latest COVID-19 research on dexamethasone, hydroxychloroquine, a vaccine, tocilizumab
Peer-reviewed details on the recent trial of dexamethasone were released, and two new trials found no benefit to early treatment with hydroxychloroquine. Positive data from a phase 1 vaccine trial were also published, as was another study of tocilizumab.
https://immattersacp.org/weekly/archives/2020/07/21/1.htm
21 Jul 2020
False positives on syphilis test after COVID-19 vaccination
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/02/false-positives-on-syphilis-test-after-covid-19-vaccination.htm
1 Feb 2022
Recent guidance offered on preparing to treat COVID-19
ACP has developed a new practice management resource on telehealth care in response to the novel coronavirus disease (COVID-19) and continues to press the U.S. government to do more to address the pandemic.
https://immattersacp.org/weekly/archives/2020/03/17/1.htm
17 Mar 2020
Warning on medication confusion, recalls due to sterility
This update covers possible confusion between an antidepressant and an anti-clotting drug, as well as 2 sterility warnings.
https://immattersacp.org/archives/2015/10/fda.htm
1 Oct 2015
HIV and chronic HBV/HCV co-infection may increase non-Hodgkin's lymphoma risk
Co-infected patients with poor immune status or restoration are at high risk for non-Hodgkin's lymphoma and death and deserve high priority for access to well-tolerated, interferon-free, direct-acting antiviral treatment programs, study authors noted.
https://immattersacp.org/weekly/archives/2016/10/18/2.htm
18 Oct 2016
Details on COVID-19 treatments authorized for outpatients
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/03/details-on-covid-19-treatments-authorized-for-outpatients.htm
1 Mar 2022
Warnings on prostate drugs, HIV combination therapy
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/01/fda.htm
1 Jan 2011